
Keywords: AC; adenocarcinomas; AdIL-32; adenoviral overexpression of IL-32; AICD; activation-induced cell death; BAVECs; bovine aortic vascular endothelial cells; BLP; bacterial lipoprotein; CML; chronic myeloid leukemia; Con A; concanavalin A; COPD; chronic obstru